HEALTH● LOWAug 20 · Aug 20, 2026, 6:16 PM
mRNA Vaccine May Extend High-Risk Melanoma Remission
Human Progress
“An experimental mRNA vaccine allowed people with high-risk melanoma to live longer, cancer-free, the pharmaceutical companies Moderna and Merck announced Wednesday. For decades, cancer vaccines have been one of the most tantalizing ideas in cancer treatment — offering the hope of harnessing a person’s own immune system to attack tumors… In the late-stage trial of […] The post mRNA Vaccine May Extend High-Risk Melanoma Remission appeared first on Human Progress.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH39m agoFrance reports first human case of Shamonda virus, but says there's no public health riskFrance 24 [en]HEALTH44m agoWhat to eat to have younger-looking skin?BBC AfriqueHEALTH47m agoLA HBCU Xavier University To Open Medical Schoolkfbk.iheart.com · United StatesHEALTH47m agoGetting health insurance from your job will be extra pricey for 2027kimt.com · United States